Consumer health care giant Haleon plans to sell its nicotine replacement therapy (NRT) business outside of the U.S. to Dr. Reddy’s Laboratories in a deal worth $633 million. A June 26 press release ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results